The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 9 , ISSUE 1 ( January, 2008 ) > List of Articles


Tuberculosis: Infection Control/Exposure Control Issues for Oral Healthcare Workers

Geza T. Terezhalmy, Nuala B. Porteous

Citation Information : Terezhalmy GT, Porteous NB. Tuberculosis: Infection Control/Exposure Control Issues for Oral Healthcare Workers. J Contemp Dent Pract 2008; 9 (1):1-13.

DOI: 10.5005/jcdp-9-1-1

License: CC BY-NC 3.0

Published Online: 01-03-2009

Copyright Statement:  Copyright © 2008; The Author(s).



The aim is to present the essential elements of an infection control/exposure control plan for the oral healthcare setting with emphasis on tuberculosis (TB).

Methods and Materials

A comprehensive review of the literature was conducted with special emphasis on TB infection-control issues in the oral healthcare setting.


Currently available knowledge related to TB infection-control issues is supported by data derived from well-conducted trials or extensive controlled observations. In the absence of supportive data the information is supported with the best-informed, most authoritative opinion available.


Essential elements of an effective TB infection-control plan include a three-level hierarchy of administrative, environmental, and respiratory-protection controls.

Clinical Significance

Standard precautions provide the fabric for strategies to prevent or reduce the risk of exposure to bloodborne pathogens and other potentially infectious material. However, standard precautions are inadequate to prevent the spread of organisms through droplet nuclei 1-5 micron in diameter and additional measures are necessary to prevent the spread of Mycobacterium tuberculosis. Oral healthcare settings have been identified as outpatient settings in which patients with suspected or confirmed infectious TB disease are expected to be encountered. Therefore, oral healthcare settings must have a written TB infection-control program.


Porteous NB, Terezhalmy GT. Tuberculosis: Infection Control/Exposure Control Issues for Oral Healthcare Workers. J Contemp Dent Pract 2008 January; (9)1:001-013.

PDF Share
  1. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, 2005. MMWR 2005;44(No, RR-17).
  2. Tuberculosis and the health care worker: A Historical Perspective. Ann Intern Med 1994;120(1):71-77.
  3. Diagnostic standards and classification of tuberculosis in adults and children. An J Respir Crit Care Med 2000;161:1376-1395.
  4. MMWR 2003;52 (No. RR-11).
  5. Aerodynamics of droplet nuclei. In: Airborne contagion and air hygiene. Cambridge, MA: Harvard University Press; 1955:13-19.
  6. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(No. RR-6).
  7. Environmental control of tuberculosis. Med Clin N Amer 1993;77(6):1315-1334.
  8. CD8+ T cells in tuberculosis. Am J Respir Crit Care Med 2002;166:1116-1121.
  9. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 2001;104:477-485.
  10. Primary tuberculosis. Curr Opin Pulm Med 2001;7:133-141.
  11. World TB day- March 24, 2004. MMWR 2004;53(10):209-214.
  12. Trends in Tuberculosis – United States, 2005. MMWR 2006;55(No 11):305-308.
  13. Transmission of tuberculosis to hospital workers by a patient with AIDS. Chest 1992;101:581-582.
  14. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol Cell Biol 2000;78:334-341.
  15. A prospective study of the risk of tuberculosis amond intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-550.
  16. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, 1994. MMWR 1994;43(No, RR-13).
  17. Mycobacterial infection of the head and neck: presentation and diagnosis. Laryngoscope 2001;111:2012-2016.
  18. Tuberculosis of the larynx. Br Med J 1966;2:991-992.
  19. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003;16)3);463-496.
  20. Oral tuberculosis: a clinical evaluation of 42 cases. Oral Dis 2000;6:25-30.
  21. Oral Dis 2003;9:46-48.
  22. Tuberculous tongue. JAMA 1978;235:2418.
  23. The epidemiological profile of tuberculosis in southern Brazil in times of AIDS. Int J Tuberc Lung Dis 2004;8:785-791.
  24. Tuberculosis tuberculosis affecting the oral cavity in Brazilian HIV-infected patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:179-182.
  25. Primary tuberculosis of the tongue: report of a case. J Oral Maxillofac Surg 1989;47:744-746.
  26. Primary tuberculosis of the oral cavity. Oral Surg Oral Med Oral Pathol 1991;72:712-715.
  27. Primary lingual tuberculosis caused by M bovis infection. Oral Surg Oral Med Oral Pathol 1995;80:172-174.
  28. Oral tuberculosis. Oral Surg Oral Med Oral Pathol 1996;81:415-420.
  29. Tuberculosis of the oral mucosa: report of a case. Ann Otol Rhinol Laryngol 1970;79:601-605.
  30. Lupus vulgaris of the oral mucosa. Report of four cases associated with asymptomatic pulmonary tuberculosis. Dermatologica 1981;162:183-190.
  31. Tuberculosis initially diagnosed by asymptomatic oral lesions: report of three cases. J Oral Med 1985:40:39-42.
  32. Oral tuberculosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:415-420.
  33. Tuberculosis of the oral cavity: a case report. Quintessence Int 1997;28(11):745-747.
  34. Tuberculoma of the tongue presenting as macroglossia. Cutis 1997;60:201-202.
  35. Primary tuberculosis of the tongue. Ear Nose Throat J 1989;68:718-720.
  36. Tuberculosis of the soft palate: an unusual presentation of tuberculosis. Otolaryngol Head Neck Surg 1987;97:91-92.
  37. Tuberculous osteomyelitis of the mandible: a case report. Int J Paediatr Dent 2001;11:304-308.
  38. Tuberculous parotitis: report of 3 case. Br J Oral Maxillofac Surg 2001;39:320-323.
  39. Mycobacterial disease of the patotid gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:292-298.
  40. Diffuse tuberculous patotitis. J Laryngol Otol 1992;106:1094-1095.
  41. Tuberculosis and human immunodeficiency virus infection: Recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR 1989;38:236-238; 243-250.
  42. Skin Testing in the Diagnosis of Tuberculosis. Res Inf 1986;1(4):234-8.
  43. Tuberculin Test. Variability with the Mantoux Procedure. A Rev Respir Dis 1985;132:175-7.
  44. Guidelines for using QuantiFERON?-TB Gold test for detecting Mycobacterium tuberculosis infection in the United States. MMWR 2005;54(No, RR-15):49-55.
  45. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994;271:698-702.
  46. Protective effect of BCG against tuberculous meningitis and military tuberculosis: a meta-analysis. Int J Epidemiology 1993;22:1154-1158.
  47. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J Clin Invest 2005;115:2472-2479.
  48. The bacterial cell wall as a structure of antibacterial targets. Expert Opin Ther targets 2002;6:1019.
  49. The envelop of mycobacteria. Ann Rev Biochem 1995;64:29-63.
  50. Multidrug-resistance Mucobacterium tuberculosis: molecular perspectives. Emerg Infect Dis 1998;4:195-209.
  51. (ed). Drugs for tuberculosis. Treat Guidel Med Lett 2004;2(28):83-88.
  52. Controlled chemoprophylaxis trials in tuberculosis. A general overview. Adv Tuberc Res 1970;17:28-106.
  53. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-138.
  54. The risk of tuberculous infection in the Netherlands from 1967 to 1979. Tubercle 1983;64:241-253.
  55. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 1997;278:304-307.
  56. Preventing and control of tuberculosis in U.S. communities with at-risk minority populations: Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1992;41(RR-5):1011.
  57. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA 1986;256(3):362-6.
  58. Human immunodeficiency virus infection in tuberculosis patients. J Infect. Dis 1990;162: 8-12.
  59. Prevalence of human immunodeficiency virus among patients attending tuberculosis clinics in the United States. J Infect Dis 1992;165:87-92.
  60. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-550
  61. Considering the role of four months of rifampin in the treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2004;170:832-835.
  62. Adverse events associated with pyrazinamide and levoflozacin in the treatment of latent multidrug-resistant tuberculosis. CMAJ 2002;167(2):131-136.
  63. Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacilin. Clin Infect Dis 1997;24:1264-1265.
  64. Congenital pulmonary tuberculosis associated with maternal cerebral tuberculosis. MMWR 2005:54(No.10):249-250.
  65. Brief report: congenital tuberculosis. N Engl J Med 1994;330:1051-1054.
  66. Congenital tuberculosis. Aust Paediartr J 1989;25:366-367.
  67. Cngenital tuberculosis. Australas Radiol 1998;43:256-257.
  68. Drug treatment for tuberculosis during pregnancy. Drug Safety 2001;24(7):553-565.
  69. Spread of organisms from dental air rotor. J Am Dent Assoc 1964; 68:648-51.
  70. Droplet nuclei produced during dental treatment of tubercular patients. A preliminary study. Oral Surg Oral Med Oral Pathol 1970;30:711-715.
  71. Self-reported tuberculin testing among Indian Health Service and Bureau of Prisons dentists, 1993. MMWR 1994;43:209-211.
  72. Tuberculosis infection in US Air Force dentists. Am J Dent 1995;8:33-36.
  73. Tuberculin skin test conversion rate in dental health care workers – results of a prospective study. Am J Infect Control 1999;27:385-387.
  74. Knowledge, attitudes, behavior and prevalence of TB infection among dentists in the western Cape. SADJ 2002;57:476-478.
  75. Intaoral and pulmonary tuberculosis following dental treatment. Lancet 1982;8276:842-844.
  76. Multidrugresistant Mycobacterium tuberculosis in an HIV dental clinic. Infect Control Hosp Epidemiol 1995;16:7-11.
  77. TB infection control recommendations from the CDC, 1994. J Am Dent Assoc 1995;126:593-597.
  78. Guidelines for Infection Control in Dental Health-Care Settings-2003. MMWR 2003:52(No. RR-17)1-68.
  79. Centers for Disease Control and Prevention Guidelines for infection control in the dental health care setting-2003. J Am Dent Assoc 2004;135:33-47.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.